Myriad Genetics
MYGN
MYGN
234 hedge funds and large institutions have $3.41B invested in Myriad Genetics in 2015 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 74 increasing their positions, 89 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 31
17% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 89
Holders
234
Holding in Top 10
5
Calls
$33.7M
Puts
$32.7M
Top Buyers
| 1 | +$32.9M | |
| 2 | +$18.5M | |
| 3 | +$18.2M | |
| 4 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
+$15.9M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$15.3M |
Top Sellers
| 1 | -$24.1M | |
| 2 | -$20.7M | |
| 3 | -$19.6M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$19.6M |
| 5 |
PIM
Provident Investment Management
Novi,
Michigan
|
-$12.8M |